Digital Device Users Who Are Treated With Systane Hydration PF
Status:
Recruiting
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
Systane Hydration PF is a recently released preservative-free artificial tear that is able to
supplement the ocular surface's moisture while simultaneously soothing the eye. While Systane
Hydration PF should in theory improve the symptoms and subsequently the quality of life of
patients who have DES, this clinical application has yet to be tested. This drop furthermore
is available in both unit-dose and multi-dose options; however, it is unclear if patient
perceive a difference between the two dispensing methods. Therefore, the primary purpose of
this study is to recruit patients who have DES and to treat them with Systane Hydration PF
and determine how regular use of this drop impacts a patient's ocular surface symptoms and
overall quality of life. This study will secondarily compare the two dispensing methods to
determine if patients prefer one method over the other.